Pelvic Organ Prolapse (POP)
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Cosm MedicalNovel Personalizable Pessary
ColoplastRestorelle Direct Fix A&P
Human BioSciencesSSLF
Clinical Trials (3)
Total enrollment: 448 patients across 3 trials
Evaluation of a Personalizable Pessary for Pelvic Organ Prolapse
Start: Apr 2026Est. completion: Oct 202643 patients
N/ANot Yet Recruiting
Restorelle Direct Fix Anterior and Posterior (A&P) for Female Pelvic Organ Prolapse: A Prospective Post Market Study
Start: Jun 2011Est. completion: Sep 201331 patients
N/ACompleted
Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
Start: Feb 2008Est. completion: Jul 2013374 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.